| 1 | the editorial and publication | | | | | | | 2 | 0.23% |
| 2 | the website these cookies | | | | | | | 2 | 0.23% |
| 3 | the level of support | | | | | | | 2 | 0.23% |
| 4 | cmas book project cytojournal | | | | | | | 1 | 0.11% |
| 5 | publication expenses of open | | | | | | | 1 | 0.11% |
| 6 | expenses of open access | | | | | | | 1 | 0.11% |
| 7 | publications such as cmas | | | | | | | 1 | 0.11% |
| 8 | such as cmas journal | | | | | | | 1 | 0.11% |
| 9 | as cmas journal cmas | | | | | | | 1 | 0.11% |
| 10 | cmas journal cmas book | | | | | | | 1 | 0.11% |
| 11 | journal cmas book project | | | | | | | 1 | 0.11% |
| 12 | project cytojournal etc in | | | | | | | 1 | 0.11% |
| 13 | book project cytojournal etc | | | | | | | 1 | 0.11% |
| 14 | editorial and publication expenses | | | | | | | 1 | 0.11% |
| 15 | cytopathology 3 future activities | | | | | | | 1 | 0.11% |
| 16 | 3 future activities may | | | | | | | 1 | 0.11% |
| 17 | future activities may include | | | | | | | 1 | 0.11% |
| 18 | activities may include publication | | | | | | | 1 | 0.11% |
| 19 | may include publication and | | | | | | | 1 | 0.11% |
| 20 | marketing of cytopathology related | | | | | | | 1 | 0.11% |
| 21 | of cytopathology related literature | | | | | | | 1 | 0.11% |
| 22 | cytopathology related literature to | | | | | | | 1 | 0.11% |
| 23 | and publication expenses of | | | | | | | 1 | 0.11% |
| 24 | skip to content cf | | | | | | | 1 | 0.11% |
| 25 | support the editorial and | | | | | | | 1 | 0.11% |
| 26 | study of cells for | | | | | | | 1 | 0.11% |
| 27 | the advancement of art | | | | | | | 1 | 0.11% |
| 28 | advancement of art and | | | | | | | 1 | 0.11% |
| 29 | of art and science | | | | | | | 1 | 0.11% |
| 30 | art and science of | | | | | | | 1 | 0.11% |
| 31 | cytopathology dedicated to the | | | | | | | 1 | 0.11% |
| 32 | dedicated to the study | | | | | | | 1 | 0.11% |
| 33 | to the study of | | | | | | | 1 | 0.11% |
| 34 | the study of cells | | | | | | | 1 | 0.11% |
| 35 | of cells for proper | | | | | | | 1 | 0.11% |
| 36 | literature to generate funds | | | | | | | 1 | 0.11% |
| 37 | cells for proper disease | | | | | | | 1 | 0.11% |
| 38 | management activities 1 | | | | | | | 1 | 0.11% |
| 39 | activities 1 support | | | | | | | 1 | 0.11% |
| 40 | activities 1 support the | | | | | | | 1 | 0.11% |